<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337977</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1195</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14091195</ELocationID><Abstract><AbstractText>This study aims to develop and apply multistate models to estimate, forecast, and manage hospital length of stay during the COVID-19 epidemic without using any external packages. Data from Bellvitge University Hospital in Barcelona, Spain, were analyzed, involving 2285 hospitalized COVID-19 patients with moderate to severe conditions. The implemented multistate model includes transition probabilities and risk rates calculated from transitions between defined states, such as admission, ICU transfer, discharge, and death. In addition to examining key factors like age and gender, diabetes, lymphocyte count, comorbidity burden, symptom duration, and different COVID-19 waves were analyzed. Based on the model, patients hospitalized stay an average of 11.90 days before discharge, 2.84 days before moving to the ICU, or 34.21 days before death. ICU patients remain for about 24.08 days, with subsequent stays of 124.30 days before discharge and 35.44 days before death. These results highlight hospital stays' varying durations and trajectories, providing critical insights into patient flow and healthcare resource utilization. Additionally, it can predict ICU peak loads for specific subgroups, aiding in preparedness. Future work will integrate the developed code into the hospital's Health Information System (HIS) following ISO 13606 EHR standards and implement recursive methods to enhance the model's efficiency and accuracy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohammadi</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Biomedical Engineering Department, Engineering Faculty, University of Isfahan, Isfahan 81746-73441, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marateb</LastName><ForeName>Hamid Reza</ForeName><Initials>HR</Initials><Identifier Source="ORCID">0000-0003-4408-2397</Identifier><AffiliationInfo><Affiliation>Biomedical Engineering Department, Engineering Faculty, University of Isfahan, Isfahan 81746-73441, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Automatic Control (ESAII), Biomedical Engineering Research Centre (CREB), Universitat Politèncicna de Catalunya (UPC), 08028 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Momenzadeh</LastName><ForeName>Mohammadreza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Artificial Intelligence, Smart University of Medical Sciences, Tehran 1553-1, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolkewitz</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, 79104 Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio-Rivas</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9548-1374</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Bellvitge University Hospital, Hospitalet de Llobregat, 08907 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020 BP 00261</GrantID><Agency>Beatriu de Pinós post-doctoral programme from the Office of the Secretary of Universities and Research from the Ministry of Business and Knowledge of the Government of Catalonia</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">comorbidity</Keyword><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">hospital length of stay</Keyword><Keyword MajorTopicYN="N">lymphocytes</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">multistate model</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337977</ArticleId><ArticleId IdType="pmc">PMC11433282</ArticleId><ArticleId IdType="doi">10.3390/life14091195</ArticleId><ArticleId IdType="pii">life14091195</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization   [(accessed on 17 September 2024)].  Available online:  https://www.emro.who.int/health-topics/infectious-diseases/index.html.</Citation></Reference><Reference><Citation>Dangerfield C., Fenichel E.P., Finnoff D., Hanley N., Hargreaves Heap S., Shogren J.F., Toxvaerd F. Challenges of integrating economics into epidemiological analysis of and policy responses to emerging infectious diseases. Epidemics. 2022;39:100585. doi: 10.1016/j.epidem.2022.100585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2022.100585</ArticleId><ArticleId IdType="pmc">PMC9124042</ArticleId><ArticleId IdType="pubmed">35636312</ArticleId></ArticleIdList></Reference><Reference><Citation>Anka A.U., Tahir M.I., Abubakar S.D., Alsabbagh M., Zian Z., Hamedifar H., Sabzevari A., Azizi G. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management. Scand. J. Immunol. 2021;93:e12998. doi: 10.1111/sji.12998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12998</ArticleId><ArticleId IdType="pmc">PMC7744910</ArticleId><ArticleId IdType="pubmed">33190302</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO COVID-19 Dashboard.  [(accessed on 1 January 2024)].  Available online:  https://data.who.int/dashboards/covid19/cases?n=c.</Citation></Reference><Reference><Citation>Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R. StatPearls. StatPearls Publishing LLC; Treasure Island, FL, USA: 2023. Features, Evaluation, and Treatment of Coronavirus (COVID-19)</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Hougaard P. Multi-state models: A review. Lifetime Data Anal. 1999;5:239–264. doi: 10.1023/A:1009672031531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1009672031531</ArticleId><ArticleId IdType="pubmed">10518372</ArticleId></ArticleIdList></Reference><Reference><Citation>Meira-Machado L., de Uña-Alvarez J., Cadarso-Suárez C., Andersen P.K. Multi-state models for the analysis of time-to-event data. Stat. Methods Med. Res. 2009;18:195–222. doi: 10.1177/0962280208092301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280208092301</ArticleId><ArticleId IdType="pmc">PMC2692556</ArticleId><ArticleId IdType="pubmed">18562394</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.K., Keiding N. Multi-state models for event history analysis. Stat. Methods Med. Res. 2002;11:91–115. doi: 10.1191/0962280202SM276ra.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0962280202SM276ra</ArticleId><ArticleId IdType="pubmed">12040698</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone K., Zwiggelaar R., Jones P., Mac Parthaláin N. A systematic review of the prediction of hospital length of stay: Towards a unified framework. PLoS Digit. Health. 2022;1:e0000017. doi: 10.1371/journal.pdig.0000017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pdig.0000017</ArticleId><ArticleId IdType="pmc">PMC9931263</ArticleId><ArticleId IdType="pubmed">36812502</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek H., Cho M., Kim S., Hwang H., Song M., Yoo S. Analysis of length of hospital stay using electronic health records: A statistical and data mining approach. PLoS ONE. 2018;13:e0195901. doi: 10.1371/journal.pone.0195901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0195901</ArticleId><ArticleId IdType="pmc">PMC5898738</ArticleId><ArticleId IdType="pubmed">29652932</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno H., Ross J.S., Wang Y., Chen J., Vidán M.T., Normand S.L., Curtis J.P., Drye E.E., Lichtman J.H., Keenan P.S., et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA. 2010;303:2141–2147. doi: 10.1001/jama.2010.748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.748</ArticleId><ArticleId IdType="pmc">PMC3020983</ArticleId><ArticleId IdType="pubmed">20516414</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Vieillard-Baron A., Evrard B., Prat G., Chew M.S., Balik M., Clau-Terré F., De Backer D., Mekontso Dessap A., Orde S., et al. Echocardiography phenotypes of right ventricular involvement in COVID-19 ARDS patients and ICU mortality: Post-hoc (exploratory) analysis of repeated data from the ECHO-COVID study. Intensive Care Med. 2023;49:946–956. doi: 10.1007/s00134-023-07147-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07147-z</ArticleId><ArticleId IdType="pubmed">37436445</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Jiménez P., Méndez R., Latorre A., Piqueras M., Balaguer-Cartagena M.N., Moscardó A., Alonso R., Hervás D., Reyes S., Menéndez R. Neutrophil Extracellular Traps and Platelet Activation for Identifying Severe Episodes and Clinical Trajectories in COVID-19. Int. J. Mol. Sci. 2023;24:6690. doi: 10.3390/ijms24076690.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076690</ArticleId><ArticleId IdType="pmc">PMC10094814</ArticleId><ArticleId IdType="pubmed">37047662</ArticleId></ArticleIdList></Reference><Reference><Citation>Edmundson J., Skoblenick K., Rosychuk R.J. Flow through the Emergency Department for Patients Presenting with Substance Use Disorder in Alberta, Canada. West. J. Emerg. Med. 2023;24:717–727. doi: 10.5811/WESTJEM.60350.</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/WESTJEM.60350</ArticleId><ArticleId IdType="pmc">PMC10393443</ArticleId><ArticleId IdType="pubmed">37527379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazard D., Kaier K., von Cube M., Grodd M., Bugiera L., Lambert J., Wolkewitz M. Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: A multistate approach. BMC Med. Res. Methodol. 2020;20:206. doi: 10.1186/s12874-020-01082-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-020-01082-z</ArticleId><ArticleId IdType="pmc">PMC7507941</ArticleId><ArticleId IdType="pubmed">32781984</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerrett M., Nau C.L., Young D.R., Butler R.K., Batteate C.M., Padilla A., Tartof S.Y., Su J., Burnett R.T., Kleeman M.J. Air pollution and the sequelae of COVID-19 patients: A multistate analysis. Environ. Res. 2023;236:116814. doi: 10.1016/j.envres.2023.116814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2023.116814</ArticleId><ArticleId IdType="pubmed">37558120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A.S., Sheikh D., Chandler T.R., Furmanek S., Huang J., Ramirez J.A., Arnold F., Cavallazzi R. Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients with SARS-CoV-2 Community-Acquired Pneumonia. Chest. 2023;163:1051–1060. doi: 10.1016/j.chest.2022.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.11.013</ArticleId><ArticleId IdType="pmc">PMC9674393</ArticleId><ArticleId IdType="pubmed">36410493</ArticleId></ArticleIdList></Reference><Reference><Citation>International Conference on Prevention and Infection Control 2023. Antimicrob. Resist. Infect. Control. 2023;12:81. doi: 10.1186/s13756-023-01276-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-023-01276-2</ArticleId><ArticleId IdType="pmc">PMC4474787</ArticleId><ArticleId IdType="pubmed">28256991</ArticleId></ArticleIdList></Reference><Reference><Citation>58th EASD Annual Meeting of the European Association for the Study of Diabetes. Diabetologia. 2022;65:1–469. doi: 10.1007/s00125-022-05755-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05755-w</ArticleId><ArticleId IdType="pmc">PMC9362525</ArticleId><ArticleId IdType="pubmed">35920845</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw P.A., Yang J.B., Mowery D.L., Schriver E.R., Mahoney K.B., Bar K.J., Ellenberg S.S. Determinants of hospital outcomes for patients with COVID-19 in the University of Pennsylvania Health System. PLoS ONE. 2022;17:e0268528. doi: 10.1371/journal.pone.0268528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0268528</ArticleId><ArticleId IdType="pmc">PMC9119468</ArticleId><ArticleId IdType="pubmed">35588434</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopher H.J., Francesca G., Kevin K., Alice C., Maria G., Marcello T., Silvana C., Danilo C., Daniela De A., Anne P. Trends in outcomes following COVID-19 symptom onset in Milan: A cohort study. BMJ Open. 2022;12:e054859. doi: 10.1136/bmjopen-2021-054859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-054859</ArticleId><ArticleId IdType="pmc">PMC8948075</ArticleId><ArticleId IdType="pubmed">35332039</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehri A., Sotoodeh Ghorbani S., Farhadi-Babadi K., Rahimi E., Barati Z., Taherpour N., Izadi N., Shahbazi F., Mokhayeri Y., Seifi A., et al. Risk Factors Associated with Severity and Death from COVID-19 in Iran: A Systematic Review and Meta-Analysis Study. J. Intensive Care Med. 2023;38:825–837. doi: 10.1177/08850666231166344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666231166344</ArticleId><ArticleId IdType="pmc">PMC10051011</ArticleId><ArticleId IdType="pubmed">36976873</ArticleId></ArticleIdList></Reference><Reference><Citation>Peña-Ramos J.A., Recuero-López F., Sánchez-Bayón A., Sastre F.J. Evaluation of Spanish Health System during the COVID-19 Pandemic: Accountability and Wellbeing Results. Int. J. Environ. Res. Public Health. 2021;18:12907. doi: 10.3390/ijerph182412907.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182412907</ArticleId><ArticleId IdType="pmc">PMC8701968</ArticleId><ArticleId IdType="pubmed">34948518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagus P., Peña-Ramos J.A., Sánchez-Bayón A. COVID-19 and the Political Economy of Mass Hysteria. Int. J. Environ. Res. Public Health. 2021;18:1376. doi: 10.3390/ijerph18041376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18041376</ArticleId><ArticleId IdType="pmc">PMC7913136</ArticleId><ArticleId IdType="pubmed">33546144</ArticleId></ArticleIdList></Reference><Reference><Citation>Statista   [(accessed on 17 September 2024)].  Available online:  https://www.statista.com/statistics/1102882/cases-of-coronavirus-confirmed-in-spain-in-2020-by-region/</Citation></Reference><Reference><Citation>Alimohamadi Y., Yekta E.M., Sepandi M., Sharafoddin M., Arshadi M., Hesari E. Hospital length of stay for COVID-19 patients: A systematic review and meta-analysis. Multidiscip. Respir. Med. 2022;17:856. doi: 10.4081/mrm.2022.856.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/mrm.2022.856</ArticleId><ArticleId IdType="pmc">PMC9472334</ArticleId><ArticleId IdType="pubmed">36117876</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostin L.O., Friedman E.A., Wetter S.A. Responding to Covid-19: How to Navigate a Public Health Emergency Legally and Ethically. Hast. Cent. Rep. 2020;50:8–12. doi: 10.1002/hast.1090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hast.1090</ArticleId><ArticleId IdType="pmc">PMC7228225</ArticleId><ArticleId IdType="pubmed">32219845</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenas Jimenez M.D., Méndez A., Furaz K., Botella A., Yetman D., Cazar R., Cabana M.L., Handel M., Sanchez M.L., Delgado M., et al. Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres. Clin. Kidney J. 2022;15:1340–1347. doi: 10.1093/ckj/sfac094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfac094</ArticleId><ArticleId IdType="pmc">PMC9217639</ArticleId><ArticleId IdType="pubmed">35756749</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinuka O., Hazard D., Marateb H.R., Mansourian M., Mañanas M.Á., Romero S., Rubio-Rivas M., Wolkewitz M. Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: Pitfalls and potential. Front. Med. 2024;11:1362192. doi: 10.3389/fmed.2024.1362192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2024.1362192</ArticleId><ArticleId IdType="pmc">PMC10991758</ArticleId><ArticleId IdType="pubmed">38576716</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinuka O., Hazard D., Marateb H.R., Maringe C., Mansourian M., Rubio-Rivas M., Wolkewitz M. Target trial emulation with multi-state model analysis to assess treatment effectiveness using clinical COVID-19 data. BMC Med. Res. Methodol. 2023;23:197. doi: 10.1186/s12874-023-02001-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-023-02001-8</ArticleId><ArticleId IdType="pmc">PMC10474639</ArticleId><ArticleId IdType="pubmed">37660025</ArticleId></ArticleIdList></Reference><Reference><Citation>von Cube M., Schumacher M., Wolkewitz M. Basic parametric analysis for a multi-state model in hospital epidemiology. BMC Med. Res. Methodol. 2017;17:111. doi: 10.1186/s12874-017-0379-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0379-4</ArticleId><ArticleId IdType="pmc">PMC5520301</ArticleId><ArticleId IdType="pubmed">28728582</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Mao B., Liang S., Yang J.W., Lu H.W., Chai Y.H., Wang L., Zhang L., Li Q.H., Zhao L., et al. Association between age and clinical characteristics and outcomes of COVID-19. Eur. Respir. J. 2020;55:2001112. doi: 10.1183/13993003.01112-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01112-2020</ArticleId><ArticleId IdType="pmc">PMC7173682</ArticleId><ArticleId IdType="pubmed">32312864</ArticleId></ArticleIdList></Reference><Reference><Citation>Marateb H.R., von Cube M., Sami R., Haghjooy Javanmard S., Mansourian M., Amra B., Soltaninejad F., Mortazavi M., Adibi P., Khademi N., et al. Absolute mortality risk assessment of COVID-19 patients: The Khorshid COVID Cohort (KCC) study. BMC Med. Res. Methodol. 2021;21:146. doi: 10.1186/s12874-021-01340-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01340-8</ArticleId><ArticleId IdType="pmc">PMC8278186</ArticleId><ArticleId IdType="pubmed">34261439</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Z., Zhang Z., Prajapati M., Li Y. Lymphopenia Caused by Virus Infections and the Mechanisms Beyond. Viruses. 2021;13:1876. doi: 10.3390/v13091876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091876</ArticleId><ArticleId IdType="pmc">PMC8473169</ArticleId><ArticleId IdType="pubmed">34578457</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabião J., Sassi B., Pedrollo E.F., Gerchman F., Kramer C.K., Leitão C.B., Pinto L.C. Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age. Braz. J. Med. Biol. Res. 2022;55:e11711. doi: 10.1590/1414-431x2021e11711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431x2021e11711</ArticleId><ArticleId IdType="pmc">PMC8856598</ArticleId><ArticleId IdType="pubmed">35195196</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi R., Lui B., Aaronson J.A., White R.S., Samuels J.D. COVID-19 complications in males and females: Recent developments. J. Comp. Eff. Res. 2022;11:689–698. doi: 10.2217/cer-2022-0027.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/cer-2022-0027</ArticleId><ArticleId IdType="pmc">PMC9149780</ArticleId><ArticleId IdType="pubmed">35510532</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Klein S.L., Garibaldi B.T., Li H., Wu C., Osevala N.M., Li T., Margolick J.B., Pawelec G., Leng S.X. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res. Rev. 2021;65:101205. doi: 10.1016/j.arr.2020.101205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101205</ArticleId><ArticleId IdType="pmc">PMC7604159</ArticleId><ArticleId IdType="pubmed">33137510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Byrne C.D., Zheng M.H., Targher G. Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies. Nutr. Metab. Cardiovasc. Dis. 2020;30:1236–1248. doi: 10.1016/j.numecd.2020.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2020.05.014</ArticleId><ArticleId IdType="pmc">PMC7258796</ArticleId><ArticleId IdType="pubmed">32571616</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt R.I.G., Cockram C.S., Ma R.C.W., Luk A.O.Y. Diabetes and infection: Review of the epidemiology, mechanisms and principles of treatment. Diabetologia. 2024;67:1168–1180. doi: 10.1007/s00125-024-06102-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-024-06102-x</ArticleId><ArticleId IdType="pmc">PMC11153295</ArticleId><ArticleId IdType="pubmed">38374451</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Zhao X., Chen X., Liu C. Early decrease in blood lymphocyte count is associated with poor prognosis in COVID-19 patients: A retrospective cohort study. BMC Pulm. Med. 2023;23:453. doi: 10.1186/s12890-023-02767-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-023-02767-z</ArticleId><ArticleId IdType="pmc">PMC10662697</ArticleId><ArticleId IdType="pubmed">37986163</ArticleId></ArticleIdList></Reference><Reference><Citation>Toori K.U., Qureshi M.A., Chaudhry A. Lymphopenia: A useful predictor of COVID-19 disease severity and mortality. Pak. J. Med. Sci. 2021;37:1984–1988. doi: 10.12669/pjms.37.7.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.12669/pjms.37.7.4085</ArticleId><ArticleId IdType="pmc">PMC8613069</ArticleId><ArticleId IdType="pubmed">34912430</ArticleId></ArticleIdList></Reference><Reference><Citation>Argun Barış S., Boyacı H., Akhan S., Mutlu B., Deniz M., Başyiğit İ. Charlson Comorbidity Index in Predicting Poor Clinical Outcomes and Mortality in Patients with COVID-19. Turk. Thorac. J. 2022;23:145–153. doi: 10.5152/TurkThoracJ.2022.21076.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/TurkThoracJ.2022.21076</ArticleId><ArticleId IdType="pmc">PMC9449884</ArticleId><ArticleId IdType="pubmed">35404247</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavuşoğlu Türker B., Türker F., Ahbab S., Hoca E., Urvasızoğlu A.O., Cetin S.I., Ataoğlu H.E. Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in COVID-19 Patients. Int. J. Gen. Med. 2022;15:6301–6307. doi: 10.2147/IJGM.S374246.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S374246</ArticleId><ArticleId IdType="pmc">PMC9343174</ArticleId><ArticleId IdType="pubmed">35924178</ArticleId></ArticleIdList></Reference><Reference><Citation>ISO—International Organization for Standardization  The ISO 13606 EHR Standard. 2019.  [(accessed on 17 September 2024)].  Available online:  http://www.en13606.org/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>